&nbsp;

CART-cellTherapyforAdult RelapsedrefractoryLymphomaThirdorSubsequentLine.pdf

Apr 2025

Document

CART-cellTherapyforAdultRelapsedrefractoryLymphomaThirdorSubsequentLine.pdf

Apr 2025

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2024

Status: Current
ID: PET 2024-1

Mar 2025

Document

ClearCellOvarianCancerTreatmentPathwayMap.pdf

Apr 2025

Document

EndometrioidOvarianCancerTreatmentPathwayMap.pdf

Apr 2025

Document

E.1.50-CAR-TReferralWorksheet.pdf

May 2025

Regimen

CRBPPACL+PEMB

Cancer Type:

Gynecologic,

Endometrial

Intent: Adjuvant, Curative, Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Advanced Melanoma (Unresectable or Metastatic Melanoma) and Prior Ipilimumab

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

CISPPEME+PEMB

Cancer Type:

Lung,

Mesothelioma (Pleural)

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

CRBPPEME+PEMB

Cancer Type:

Lung,

Mesothelioma (Pleural)

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

CRBPPACL+PEMB

Cancer Type:

Lung,

Non-Small Cell

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Pembrolizumab - (Neo)adjuvant Therapy for Resectable Non-Small Cell Lung Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Jul 2025

Carte des voies du cancer thymique

Regimen

CEMI

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Cemiplimab - Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Drugs Used:

cemiplimab

... Show more tags